EastWest Bioscience Inc.
EASTH.V
TSX
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -442.80K | 1.65M | -385.90K | -760.00K | -120.60K |
| Total Depreciation and Amortization | 19.70K | 19.70K | 19.90K | 24.40K | 24.30K |
| Total Amortization of Deferred Charges | 9.20K | 11.30K | 11.50K | 10.80K | 8.10K |
| Total Other Non-Cash Items | 275.40K | -1.91M | -37.90K | 49.90K | -49.10K |
| Change in Net Operating Assets | 135.10K | 194.10K | 400.50K | 380.20K | 185.40K |
| Cash from Operations | -3.40K | -35.00K | 8.10K | -294.70K | 48.20K |
| Capital Expenditure | 0.00 | 0.00 | -59.20K | 0.00 | -7.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 24.80K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | -4.35M | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -4.35M | -59.20K | 24.80K | -7.50K |
| Total Debt Issued | 0.00 | 20.00K | -- | 7.70K | 60.00K |
| Total Debt Repaid | 0.00 | 0.00 | -20.00K | -20.00K | -20.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 4.59M | -- | 1.28M | -- |
| Cash from Financing | 0.00 | 3.64M | -15.90K | 1.03M | 31.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.40K | -747.70K | -67.00K | 762.70K | 72.50K |
